Anaphylaxis to a Vedolizumab Infusion following Drug Holiday in a Patient with Ulcerative Colitis: A Case Report
Introduction: Vedolizumab is a commonly prescribed biologic agent due to its safety profile and clinical efficacy. Severe infusion-related reactions are exceedingly rare, with no previously documented cases of anaphylaxis to vedolizumab infusion following a drug holiday. Case Presentation: We report...
Saved in:
Published in | Case reports in gastroenterology Vol. 19; no. 1; pp. 62 - 66 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
S. Karger AG
12.02.2025
Karger Publishers |
Subjects | |
Online Access | Get full text |
ISSN | 1662-0631 1662-0631 |
DOI | 10.1159/000543387 |
Cover
Loading…